Cell Growth & Differentiation, Vol 3, Issue 5 291-298, Copyright © 1992 by American Association of Cancer Research

ARTICLES

Transforming growth factor beta 1 regulation of c-myc expression, pRB phosphorylation, and cell cycle progression in keratinocytes

K Munger, JA Pietenpol, MR Pittelkow, JT Holt and HL Moses
Laboratory of Tumor Virus Biology, National Cancer Institute, Bethesda, Maryland 20892.

Transforming growth factor beta 1 (TGF-beta 1) is a potent inhibitor of cellular proliferation in a variety of cell types, including skin keratinocytes. TGF-beta 1 suppression of c-myc transcription has been implicated in the mechanism of TGF-beta 1 inhibition of keratinocytes, and evidence suggests that the protein product of the retinoblastoma gene (pRB) is a necessary component in this pathway. Following growth factor stimulation of quiescent keratinocytes, TGF-beta 1 can inhibit cell cycle progression into S phase at any point prior to the G1-S transition but does not inhibit progression through the S phase of the cell cycle. Since pRB is hypophosphorylated during G1 and hyperphosphorylated during S and G2, the G1-S-specific phosphorylation of pRB becomes an attractive target for the growth-inhibitory activities of TGF-beta 1. However, in TGF-beta 1-treated primary human keratinocytes and in a series of human papilloma virus and SV40 immortalized human keratinocyte cell lines, the phosphorylation status of pRB strictly correlated with cell growth. No evidence was found for a direct effect of TGF-beta 1 on the phosphorylation state of pRB in these cells. It was further demonstrated that synthesis of c-myc protein can be rapidly inhibited by TGF-beta 1 addition throughout G1 and S phases, indicating that the phosphorylation state of pRB, at least as it varies during the cell cycle, does not alter the ability of TGF-beta 1 to suppress c-myc expression.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				N. Ojeh, V. Pekovic, C. Jahoda, and A. Maatta The MAGUK-family protein CASK is targeted to nuclei of the basal epidermis and controls keratinocyte proliferation J. Cell Sci., August 15, 2008; 121(16): 2705 - 2717. [Abstract] [Full Text] [PDF]

				B. K. Law, A. Chytil, N. Dumont, E. G. Hamilton, M. E. Waltner-Law, M. E. Aakre, C. Covington, and H. L. Moses Rapamycin Potentiates Transforming Growth Factor {beta}-Induced Growth Arrest in Nontransformed, Oncogene-Transformed, and Human Cancer Cells Mol. Cell. Biol., December 1, 2002; 22(23): 8184 - 8198. [Abstract] [Full Text] [PDF]

				M. L. Rodriguez-Puebla, P. L. Miliani de Marval, M. LaCava, D. S. Moons, H. Kiyokawa, and C. J. Conti cdk4 Deficiency Inhibits Skin Tumor Development but Does Not Affect Normal Keratinocyte Proliferation Am. J. Pathol., August 1, 2002; 161(2): 405 - 411. [Abstract] [Full Text] [PDF]

				M. L. Rodriguez-Puebla, M. LaCava, P. L. Miliani de Marval, J. L. Jorcano, E. R. Richie, and C. J. Conti Cyclin D2 Overexpression in Transgenic Mice Induces Thymic and Epidermal Hyperplasia whereas Cyclin D3 Expression Results Only in Epidermal Hyperplasia Am. J. Pathol., September 1, 2000; 157(3): 1039 - 1050. [Abstract] [Full Text] [PDF]

				A. Glick, N. Popescu, V. Alexander, H. Ueno, E. Bottinger, and S. H. Yuspa Defects in transforming growth factor-beta signaling cooperate with a Ras oncogene to cause rapid aneuploidy and malignant transformation of mouse keratinocytes PNAS, December 21, 1999; 96(26): 14949 - 14954. [Abstract] [Full Text] [PDF]

				M. L. Rodriguez-Puebla, M. LaCava, and C. J. Conti Cyclin D1 Overexpression in Mouse Epidermis Increases Cyclin-dependent Kinase Activity and Cell Proliferation in Vivo but Does Not Affect Skin Tumor Development Cell Growth Differ., July 1, 1999; 10(7): 467 - 472. [Abstract] [Full Text]

				R. A. Steinman, J. Huang, B. Yaroslavskiy, J. P. Goff, E. D. Ball, and A. Nguyen Regulation of p21(WAF1) Expression During Normal Myeloid Differentiation Blood, June 15, 1998; 91(12): 4531 - 4542. [Abstract] [Full Text] [PDF]

				H. Kamesaki, K. Nishizawa, G. Y. Michaud, J. Cossman, and T. Kiyono TGF-{beta}1 Induces the Cyclin-Dependent Kinase Inhibitor p27Kip1 mRNA and Protein in Murine B Cells J. Immunol., January 15, 1998; 160(2): 770 - 777. [Abstract] [Full Text] [PDF]

				C. Feliciani, A.K. Gupta, and D.N. Saucier Keratinocytes and Cytokine/Growth Factors Critical Reviews in Oral Biology & Medicine, January 1, 1996; 7(4): 300 - 318. [Abstract] [Full Text] [PDF]

				A J Wagner, J M Kokontis, and N Hay Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. Genes & Dev., December 1, 1994; 8(23): 2817 - 2830. [Abstract] [PDF]

				A B Glick, M M Lee, N Darwiche, A B Kulkarni, S Karlsson, and S H Yuspa Targeted deletion of the TGF-beta 1 gene causes rapid progression to squamous cell carcinoma. Genes & Dev., October 15, 1994; 8(20): 2429 - 2440. [Abstract] [PDF]